Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-12

Clinical Trial Update: Melatonin for Pediatric Emergence Agitation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for melatonin in pediatric emergence agitation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Menoufia University | Conditions: Emergence Agitation | Phase 4 | Status: COMPLETED